United States Travelers Vaccines Market is expected to reach US$ 9,054.68 Million by 2033 | Top key players - GSK plc., Merck & Co, Inc., Pfizer Inc.

Market Size and Growth:

The Travelers Vaccines Market Size reached US$ 4,092.58 million in 2024 and is expected to reach US$ 9,054.68 million by 2033, growing at a CAGR of 8.7 % during the forecast period of 2025-2033.

The Travelers Vaccines Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/travelers-vaccines-market?sz

The Travelers Vaccines Market refers to the global industry focused on developing, producing, and distributing vaccines that protect travelers from infectious diseases encountered abroad. These vaccines help prevent illnesses such as yellow fever, typhoid, hepatitis A and B, meningococcal disease, and rabies, ensuring safe international travel and supporting global public health initiatives.

Industry Recent Developments:

United States:

✅ September 2025: The North America travel vaccines market is experiencing growth driven by increasing travel demand, government mandates, and advanced technologies such as combination vaccines and needle-free techniques.

✅ July 2025: Increased awareness for region-specific infectious diseases and preventive measures is driving higher demand for immunization prior to travel, supported by digital health platforms and government healthcare initiatives.

✅ July 2025: Key industry players like GlaxoSmithKline, Sanofi, Pfizer, and Merck are leveraging innovations in vaccine technology and expanding their global reach to respond to emerging infectious threats.

Japan:

✅ September 2025: Japan's travel vaccine market is projected to grow at a CAGR of 9.9% from 2025 to 2032, with a strong focus on injectable vaccines and rapid growth in typhoid vaccine demand.

✅ October 2025: The Japanese encephalitis vaccines market is showing emerging growth trends, reflecting heightened demand and expanded vaccination programs.

✅ September 2025: COVID-19 vaccine market in Japan valued at USD 5 billion in 2024, expected to grow with ongoing vaccination campaigns and market expansion reaching USD 7 billion by 2033.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/travelers-vaccines-market?sz

Major Key Players:

GSK plc.
Merck & Co, Inc.
Bavarian Nordic Inc.
Pfizer Inc.
Sanofi
Dynavax Technologies.
Valneva SE.
Takeda Pharmaceutical Company Limited.

Key Growth Drivers:

Rising international travel and tourism: Increasing global mobility exposes travelers to infectious diseases endemic in various regions, driving demand for preventive vaccinations before travel. This is coupled with regulatory vaccination requirements for certain destinations, boosting vaccine uptake worldwide.

Growing awareness and education: Heightened awareness among travelers about the risks of travel-related infectious diseases and the benefits of vaccination is increasing proactive immunization. Digital health platforms, government health campaigns, and travel preparation services contribute to this growth.

Government initiatives and industry collaborations: Governments promote vaccination through mandates, incentives, and public-private partnerships that support vaccine development, affordability, and accessibility. Pharmaceutical companies innovate with new vaccines and improved delivery systems to meet this demand.

Segments Covered in the Travelers Vaccines Market:

By Product Type: Cholera, Diphtheria Pertussis Tetanus (DPT), Encephalitis, Hepatitis A, Hepatitis B, Meningococcal, Influenza, Rabies, Typhoid, Yellow Fever, Others.

By Travel Type: Domestic, Outbound.

By End-User: Hospitals, Travel Clinics, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=travelers-vaccines-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Travelers Vaccines market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Travelers Vaccines Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Travelers Vaccines market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Travelers Vaccines Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Travelers Vaccines Market in 2025?
◆ What is the projected growth rate of the Travelers Vaccines Market through 2033?
◆ Who are the key players in the Travelers Vaccines Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.